Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADAM9 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ME2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | MLLT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | USP27X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | FAM3B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | DHX33 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | STIM1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | FGD1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | THAP8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | AC007906.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |